Five feature-length action adventures based on the Marvel comic.

In 'X-Men' (2000), mutants Professor Charles Xavier (Patrick Stewart) and Magneto (Ian McKellen) are former friends, but look set to become mortal enemies when fascist US senator Robert Frank Kelly calls for the registration of all humans with abnormal powers. While telepath Xavier, who runs an altruistic academy for superhuman 'X-Men', wishes to enlighten non-mutants and break down the prejudices which divide them, Magneto believes that the only solution is for the mutants to take over. Wolverine (Hugh Jackman) - an aggressive loner with an admantium skeleton and the ability to heal his body of any wound - and teenager Rogue (Anna Paquin), who can absorb the life force of others simply by touching them, are selected by Xavier to join his academy, but it isn't long before Magneto's followers are attempting to capture them so that they can assist in his plan for world domination.

In the sequel, 'X-Men 2' (2003), Xavier, Wolverine and the X-Men find themselves in the firing line after a failed assassination attempt on the president points the finger at the school. It was in fact the mysterious teleporter Nightwalker (Alan Cumming) who ordered it, and, in an attempt to clear their names, the X-Men are led into a trap set by the evil William Stryker (Brian Cox), a mysterious scientist apparently working for the government. As it soon becomes evident that Stryker's agenda is to destroy all mutants, the X-Men need to call in the help of many of their old friends and foes, including Magneto, if they are to stop him.

In the third film, 'X-Men: The Last Stand' (2006), the mutants are given the option of giving up their powers and becoming human after a private laboratory supported by the government finds a way to use the DNA of a powerful boy to correct the mutants. However, Magneto opposes and decides to join a force to fight against the government and kill the mutant boy. Meanwhile, Jean Grey (Famke Janssen) resurrects, uncontrolled by Xavier, and with the personality of the powerful Dark Phoenix. She destroys Cyclops (James Marsden) and Xavier and allies herself to the evil forces of Magneto, making them almost invincible.

The fourth film in the franchise, 'X-Men: Origins - Wolverine' (2009) is a prequel to the other three films. Hugh Jackman reprises his role as Wolverine, who, some 20 years before the action of the original movie, is seeking revenge on his half-brother Victor Creed (Liev Schreiber) for the death of his girlfriend, and eventually signs up to the ominous Weapon X programme.

Finally, 'X-Men: First Class' (2011) charts the beginning of the saga, following Professor X (James McAvoy) and Magneto (Michael Fassbender) through their formative years in the 1960s as they come to terms with their newfound superpowers. Initially close friends who work together to fight against evil, the two men are driven apart by a conflict of opinion that ultimately leads to the eternal war between Magneto's Brotherhood and Professor X's X-Men.

Seven episodes of the animated children's series following the teenaged fairies of the Winx Club as they continue to evolve and gain new fairy powers in the magical dimension of Magix. The episodes are: 'The Spill', 'The Rise of Tritannus', 'Return to Alfea', 'The Sirenix Book', 'The Lilo', 'The Power of Harmonix' and 'The Shimmering Shells'.

My father W.G.L. Tonkin was born in Bodmin in 1904 where he lived until he went to Exeter University to train as a teacher. He went to London in 1923, married and had two sons. He taught in Hackney and later became a headmaster in Westminster. He returned to Cornwall, which he loved, whenever he could. His father was a well known ironmonger who owned a shop in Fore Street. Four generations of Tonkins were ironmongers in Bodmin. After retirement he was asked by my brother, Gregory, to recount his experience of life in Bodmin when he was young. A 'Boy in Cornwall' is an account of his experiences.

The Uncapturable is a wide-ranging reflection on the art of the mise en scene from the perspective of leading Argentinian theatre director Ruben Szuchmacher. It offers a timely and concise, though comprehensive, survey of the role and responsibility of the theatre director from the earliest times to the twenty-first century. Szuchmacher defines theatre as the confluence of four art forms - architecture, visual art, sound and literature - whose works only truly exist in the moment of encounter with an audience. He argues that, by taking full account of these four art forms, analysing them in detail and engaging thoughtfully with the many specialists who come together to bring a mise en scene into being, the director of today can still create work that innovates and inspires. The Uncapturable is as valuable to the apprentice director emerging from their training as it is to the veteran in need of fresh reflection. Szuchmacher draws on the unique learnings gleaned from working in Argentina, be it the impact on theatre of politics, the need for inventiveness in times of hardship, the phenomenon of Argentine 'circus theatre' or the adaptation of literary giants such as Borges, affording the Anglophone reader an alternative perspective on the ideas of theatre we often take for granted. Szuchmacher offers a unique blend of global knowledge, historical awareness and a pragmatic, resourceful and creative approach from a theatre artist working in Latin American through decades of change. The book is translated from the Spanish by William Gregory.

Fully updated from cover to cover, Zipes and Jalife's Cardiac Electrophysiology: From Cell to Bedside, 8th Edition, provides the comprehensive, multidisciplinary coverage you need-from new knowledge in basic science to the latest clinical advances in the field. Drs. Jose Jalife and William Gregory Stevenson lead a team of global experts who provide cutting-edge content and step-by-step instructions for all aspects of cardiac electrophysiology. Packs each chapter with the latest information necessary for optimal basic research as well as patient care. Covers new technologies such as CRISPR, protein research, improved cardiac imaging, optical mapping, and wearable devices. Contains significant updates in the areas of molecular biology and genetics, iPSCs (induced pluripotent stem cells), embryonic stem cells, precision medicine, antiarrhythmic drug therapy, cardiac mapping with advanced techniques, and ablation technologies including stereotactic radioablation. Includes 47 new chapters covering both basic science and clinical topics. Discusses extensive recent progress in the understanding, diagnosis, and management of arrhythmias, including new clinical insights on atrial fibrillation and stroke prevention, new advances in the understanding of ventricular arrythmias in genetic disease, and advances in implantable devises and infection management. Features 1,600 high-quality photographs, anatomic and radiographic images, electrocardiograms, tables, algorithms, and more., with additional figures, tables, and videos online. Recipient of a 2018 Highly Commended award from the British Medical Association. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

At the age of thirteen, chemistry enthusiast Justus von Liebig (1803-73) witnessed the devastation caused by a summer of crop failure. Three decades later, Liebig had become a leading German chemist based at the University of Giessen and had made significant contributions to agriculture and medicine in addition to his pioneering work in organic chemistry. This 1842 study in animal metabolism includes detailed analysis of the chemical transformation undergone in healthy and diseased organisms. Although Liebig considers that chemical analysis alone is not sufficient to explain physiological processes driven by 'vital forces', he argues that it offers quantitative research methods that are superior to mere observation. Several of his works, including this one, were translated into English by his colleague, Scottish chemist William Gregory (1803-58). Liebig's laboratory-based teaching methods quickly gained popularity among British researchers and contributed to the founding of the Royal College of Chemistry in 1845.

Eight-year-old Garang, orphaned by a civil war in Sudan, finds the inner strength to help lead other boys as they trek hundreds of miles seeking safety in Ethiopia, then Kenya, and finally in the United States. 'Brother in Hope' is aimed at children aged seven and over.

"He said, 'The day will come when they don't cut our heads off in front of people.' And I asked him, 'Why?' And he said, 'Because we'll cut them off ourselves.'" A lecturer in Chile. A study group in the USA. A guard in the desert. A hangman in Mexico. A woman who won't stop dancing in Peru. Pablo Manzi's darkly comic odyssey across the Americas explores whether violence brings us closer together and what it takes to make a community. A Fight Against... marks the English-language debut of one of Chile's most significant new voices. It was developed on a residency at the Royal Court Theatre, London, where it premiered in December 2021 in the Jerwood Theatre Upstairs.

Completely revised and updated, Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, risk management, quality/compliance, and in government and legal professions.This comprehensive and practical guide discusses the theory and the practicalities of drug safety (also known as pharmacovigilance), and provides essential information on drug safety and regulations in the United States, Europe Union, and more, including: recognizing, monitoring, reporting, and cataloging serious adverse drug reactions.Cobert's Manual of Drug Safety and Pharmacovigilance, Third Edition, teaches the daily practice of drug safety in industry, hospitals, the FDA and other health agencies — both in the United States and around the world — and provides critical information about what to do when confronted with a drug safety problem.Related Link(s)